Translating biomarker discoveries into practical, quantitative assays can be complex, requiring considerations for throughput, reproducibility, scalability, and sensitivity. As demand grows for targeted assays in proteomics, metabolomics, and lipidomics, method development, and implementation become increasingly time-intensive and challenging.
Waters streamlines targeted omics analysis with innovative LC-MS/MS solutions that enhance your laboratory’s biomarker quantification with precision and accuracy, accelerating results, and improving efficiency. The Waters Targeted Omics Library offers ready-to-use, downloadable methods, reducing development time, and enabling your lab to stay ahead in biomarker discovery—without overextending your resources. With Waters, you can:
Add flexibility in converting sample data into valuable knowledge using Waters MassLynx Mass Spectrometry Software with improved performance while acquiring, analyzing, managing, and sharing mass spectrometry information.
Eliminate complex time-consuming manual data review and increase your laboratory productivity by converting data into useful information using Waters MassLynx Quantitation Applications, optimizing your data analysis and processing requirements.
Reduce the risks associated with unpredictable chromatography with ACQUITY Premier Columns with MaxPeak High Performance Surfaces (HPS) Technology, which allows you to see and do more by reducing analyte/surface interactions.
Optimize your laboratory's productivity and success with Waters Global Services. Maintain peak system performance, minimize downtime, address application challenges, and support stringent compliance requirements.
Maximize your lab resources and minimize risk with payment options from Waters Capital, which includes innovative solutions to upgrade aging instruments, customized support, and flexible options to bundle your complete laboratory solution in one easy monthly payment – everything you need to advance your science.
Targeted omics and biomarker quantification is the process of measuring specific molecules in biological systems to understand their role in health, disease, and treatment response. Unlike broad discovery studies that analyze thousands of molecules at once, targeted omics focuses only on a selected set of known or suspected molecules such as proteins, lipids, or metabolites that are linked to a particular biological process or condition. This focused approach provides greater accuracy and consistency, making it highly valuable for research and clinical applications.
The main advantage of targeted omics is its ability to measure biomarkers with very high sensitivity and precision. Biomarkers are molecules that can show whether the body is functioning normally, if a disease is developing, or how well a treatment is working. Advanced technologies like liquid chromatography coupled with mass spectrometry (LC-MS) make this possible by accurately detecting and quantifying these molecules even when they are present in very small amounts. Combining LC and MS helps separate and identify compounds in complex samples with confidence.
Targeted omics is widely used in different areas of science and healthcare. In clinical research, it helps confirm potential biomarkers discovered in earlier studies before they are used in diagnostics or patient care. In drug development, it supports studies on how a drug behaves in the body, how effective it is, and whether it reaches its intended target. It is also important for personalized medicine, where biomarkers guide doctors in choosing the most effective treatment for each patient.
For the best results, targeted omics requires advanced instruments and well-optimized workflows. Automated sample preparation, high-quality LC-MS systems, and powerful data analysis tools ensure accurate and reproducible results that meet regulatory standards. By enabling precise measurement of important molecules, targeted omics serves as a key link between early research and real-world clinical applications, helping to turn scientific discoveries into better healthcare solutions.